Nikolaos Efstathiou, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Pigment Epithelium | 5 | 2020 | 302 | 1.030 |
Why?
|
| Ribonucleosides | 2 | 2020 | 82 | 0.910 |
Why?
|
| Aminoimidazole Carboxamide | 2 | 2020 | 88 | 0.900 |
Why?
|
| Dysmenorrhea | 1 | 2023 | 86 | 0.860 |
Why?
|
| Complement C3 | 1 | 2020 | 461 | 0.660 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 2 | 2019 | 52 | 0.350 |
Why?
|
| Macular Degeneration | 4 | 2020 | 980 | 0.320 |
Why?
|
| Complement Activation | 2 | 2020 | 453 | 0.200 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2019 | 143 | 0.200 |
Why?
|
| Retinal Pigments | 1 | 2020 | 83 | 0.190 |
Why?
|
| Ribonucleotides | 1 | 2020 | 117 | 0.190 |
Why?
|
| Macular Edema | 1 | 2023 | 359 | 0.170 |
Why?
|
| Basement Membrane | 1 | 2019 | 356 | 0.160 |
Why?
|
| Complement Factor B | 1 | 2017 | 72 | 0.160 |
Why?
|
| Phosphotransferases (Phosphate Group Acceptor) | 1 | 2017 | 18 | 0.160 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 611 | 0.150 |
Why?
|
| GTPase-Activating Proteins | 1 | 2019 | 498 | 0.140 |
Why?
|
| Adenosine | 1 | 2020 | 825 | 0.130 |
Why?
|
| Diabetic Retinopathy | 1 | 2023 | 1210 | 0.120 |
Why?
|
| Cell Line | 4 | 2020 | 15997 | 0.110 |
Why?
|
| Photosensitizing Agents | 1 | 2017 | 602 | 0.110 |
Why?
|
| Adaptation, Psychological | 1 | 2023 | 2576 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 2077 | 0.100 |
Why?
|
| Neuroglia | 1 | 2017 | 927 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2020 | 4420 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2019 | 1736 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2019 | 2967 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2019 | 4217 | 0.090 |
Why?
|
| Antibodies | 1 | 2018 | 2460 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2020 | 8436 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2019 | 2635 | 0.080 |
Why?
|
| Retina | 1 | 2019 | 2616 | 0.080 |
Why?
|
| Proteomics | 1 | 2022 | 3638 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2017 | 2440 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2020 | 19229 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 2916 | 0.070 |
Why?
|
| Lysosomes | 2 | 2022 | 893 | 0.070 |
Why?
|
| Macrophages | 1 | 2019 | 5655 | 0.060 |
Why?
|
| Melanoma | 1 | 2023 | 5510 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 5686 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5853 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 8428 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 8037 | 0.050 |
Why?
|
| Aging | 1 | 2019 | 8664 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 9648 | 0.040 |
Why?
|
| Bruch Membrane | 1 | 2019 | 64 | 0.040 |
Why?
|
| Animals | 6 | 2022 | 168757 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 11725 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2019 | 643 | 0.040 |
Why?
|
| Tubercidin | 1 | 2017 | 16 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2023 | 495 | 0.040 |
Why?
|
| Laminin | 1 | 2019 | 419 | 0.040 |
Why?
|
| Exocytosis | 1 | 2019 | 353 | 0.040 |
Why?
|
| Corneal Neovascularization | 1 | 2019 | 188 | 0.040 |
Why?
|
| Dipyridamole | 1 | 2017 | 145 | 0.040 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2017 | 37 | 0.040 |
Why?
|
| Apolipoprotein E4 | 1 | 2022 | 668 | 0.040 |
Why?
|
| Alu Elements | 1 | 2018 | 119 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2017 | 12208 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2019 | 599 | 0.040 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2017 | 96 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 972 | 0.040 |
Why?
|
| Glutathione | 1 | 2019 | 589 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2022 | 1730 | 0.040 |
Why?
|
| Humans | 10 | 2023 | 744343 | 0.040 |
Why?
|
| Glutamine | 1 | 2019 | 578 | 0.040 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2017 | 223 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2019 | 835 | 0.030 |
Why?
|
| Caspases | 1 | 2019 | 928 | 0.030 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2019 | 664 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2022 | 1438 | 0.030 |
Why?
|
| Ribonuclease III | 1 | 2018 | 275 | 0.030 |
Why?
|
| Mice | 5 | 2022 | 81183 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2018 | 1095 | 0.030 |
Why?
|
| Lasers | 1 | 2019 | 952 | 0.030 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2018 | 375 | 0.030 |
Why?
|
| Cysteine | 1 | 2019 | 874 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1655 | 0.030 |
Why?
|
| Necrosis | 1 | 2019 | 1643 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2019 | 1959 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 697 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2019 | 14557 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2019 | 1189 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2019 | 1539 | 0.030 |
Why?
|
| Autophagy | 1 | 2022 | 1300 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2019 | 3701 | 0.030 |
Why?
|
| Imidazoles | 1 | 2019 | 1206 | 0.030 |
Why?
|
| Models, Animal | 1 | 2019 | 2171 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 1086 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 987 | 0.030 |
Why?
|
| Glucose | 1 | 2023 | 4397 | 0.020 |
Why?
|
| Indoles | 1 | 2019 | 1839 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2023 | 2872 | 0.020 |
Why?
|
| Collagen | 1 | 2019 | 2689 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2019 | 3772 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2018 | 2751 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2017 | 1660 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 3508 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 4554 | 0.020 |
Why?
|
| Female | 1 | 2023 | 380194 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2019 | 13033 | 0.020 |
Why?
|
| Apoptosis | 1 | 2019 | 9727 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 21827 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10481 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16689 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18029 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 77449 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2017 | 23403 | 0.010 |
Why?
|
| Aged | 1 | 2023 | 163280 | 0.010 |
Why?
|
| Adult | 1 | 2023 | 214055 | 0.010 |
Why?
|